
Merck (MRK) Was a Market Leader, is Now a Laggard as Money Moves
Merck (MRK) was a solid stock in 2022. Now in 2023, the shares are lagging the stock market as growth stock are in favor.
Merck (MRK) was a solid stock in 2022. Now in 2023, the shares are lagging the stock market as growth stock are in favor.
Merck (MRK) is the perfect stock for a Bear Market. Investors know this, that’s why the drug stock is doing so well right now.
Merck (MRK) is a nice safe stock to own during a rough bear Market. But investors need to understand the growth might be slow.
Merck (MRK) stock has some appeal for stock portfolios that are sick of this Bear Market. I like the low P/E of 13 and 3% yield.
Merck (MRK) is expected to report qtrly profits (EPS) and revenues:
Profits Estimates: $1.30 vs. $2.14 = -39%
Rev Est: $13,731 vs. $15,901 = -14%